Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Continue

Publications

Crossover to Photodynamic Therapy or Micropulse Laser After Failure of Primary Treatment of Chronic Central Serous Chorioretinopathy: The REPLACE Trial

van Rijssen TJ. et al, (2020), American Journal of Ophthalmology, 216, 80 - 89

"Genetic and clinical findings in an ethnically diverse retinitis pigmentosa cohort associated with pathogenic variants in EYS".

Cundy O. et al, (2020), Eye (Lond)

Next generation sequencing using phenotype-based panels for genetic testing in inherited retinal diseases.

Shah M. et al, (2020), Ophthalmic Genet, 1 - 7

Hydroxychloroquine hitting the headlines—retinal considerations

Downes SM. et al, (2020), Eye

Association of Clinical and Genetic Heterogeneity With BEST1 Sequence Variations.

Shah M. et al, (2020), JAMA Ophthalmol

Reply to Comment on: Focal and Diffuse Chronic Central Serous Chorioretinopathy Treated With Half-Dose Photodynamic Therapy or Subthreshold Micropulse Laser: PLACE Trial Report No. 3.

van Rijssen TJ. et al, (2020), Am J Ophthalmol, 212, 187 - 188

Eplerenone for chronic central serous chorioretinopathy in patients with active, previously untreated disease for more than 4 months (VICI): a randomised, double-blind, placebo-controlled trial.

Lotery A. et al, (2020), Lancet, 395, 294 - 303

Novel Heterozygous Deletion in Retinol Dehydrogenase 12 (RDH12) Causes Familial Autosomal Dominant Retinitis Pigmentosa.

Sarkar H. et al, (2020), Front Genet, 11

Phenogenon: Gene to phenotype associations for rare genetic diseases.

Pontikos N. et al, (2020), PLoS One, 15

Reanalysis of Association of Pro50Leu Substitution in Guanylate Cyclase Activating Protein-1 With Dominant Retinal Dystrophy.

Mahroo OA. et al, (2019), JAMA Ophthalmol

Transcorneal electrical stimulation for the treatment of retinitis pigmentosa – a multicenter safety study of the OkuStim® System (TESOLA-study)

Jolly J. et al, (2019), Ophthalmic Research

Clinical Characterization of Retinitis Pigmentosa Associated With Variants in SNRNP200.

Yusuf IH. et al, (2019), JAMA Ophthalmol

Atypical choroideremia presenting with early-onset macular atrophy.

Kontos G. et al, (2019), Acta Ophthalmol, 97, 633 - 636

Clinical Effectiveness of Intravitreal Therapy With Ranibizumab vs Aflibercept vs Bevacizumab for Macular Edema Secondary to Central Retinal Vein Occlusion: A Randomized Clinical Trial.

Hykin P. et al, (2019), JAMA Ophthalmol

Impact of diabetic retinopathy on sleep, mood, and quality of life.

(2019), Investigative Ophthalmology and Visual Science

Anatomical and functional outcomes following switching from aflibercept to ranibizumab in neovascular age-related macular degeneration in Europe: SAFARI study.

Gale RP. et al, (2019), Br J Ophthalmol

A Specific Macula-Predominant Retinal Phenotype Is Associated With the CDHR1 Variant c.783G>A, a Silent Mutation Leading to In-Frame Exon Skipping.

Charbel Issa P. et al, (2019), Invest Ophthalmol Vis Sci, 60, 3388 - 3397

Handheld laser devices and laser-induced retinopathy (LIR) in children: an overview of the literature.

Neffendorf JE. et al, (2019), Eye (Lond), 33, 1203 - 1214

Patient characteristics of untreated chronic central serous chorioretinopathy patients with focal versus diffuse leakage.

van Rijssen TJ. et al, (2019), Graefes Arch Clin Exp Ophthalmol, 257, 1419 - 1425

Retinitis pigmentosa caused by variants in SNRNP200

Yusuf IH. et al, (2019), INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 60

Load More

1
2
3
4
5